Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial

Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Locations were updated with new sites across multiple U.S. states and international regions (Australia, United Kingdom, Canada), and several previously listed locations were removed. This update changes the geographic footprint of the trial.
    Difference
    2%
    Check dated 2025-12-23T17:21:28.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    The update appears to be a site-wide revision tag with no changes to the study content or displayed details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T17:51:48.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page no longer displays the government funding operating-status notice. All study details, eligibility criteria, locations, and outcomes remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T17:30:47.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The study record now shows termination with the note 'Terminated Trial failed to meet primary endpoint' and the Last Update Posted date updated to 2024-07-29.
    Difference
    0.3%
    Check dated 2025-11-03T09:52:59.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Updates present: a status notice about funding-related delays and open NIH Clinical Center with links for more details, and a version bump to v3.2.0. This shifts core information and versioning; no other functional changes are evident.
    Difference
    4%
    Check dated 2025-10-05T14:28:55.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Added a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.
    Difference
    0.4%
    Check dated 2025-09-28T09:46:35.000Z thumbnail image

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.